Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
|
Regulatory Post-Marketing Surveillance Study for Brolucizumab |
Neovascular Age-related Macular Degeneration | Korea, Republic of | NCT04985487 | |
|
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) |
Relapsing Multiple Sclerosis | Phase3 |
Argentina Austria Belgium Bulgaria Chile China Colombia Croatia Denmark Georgia Guatemala Hong Kong India Ireland Israel Italy Jordan Latvia Lebanon Lithuania Malaysia Mexico Netherlands Poland Saudi Arabia Slovakia Spain Switzerland Taiwan United Arab Emirates United Kingdom United States View All
|
NCT05147220 |
|
A Post Marketing Surveillance on Piqray in Korea |
Breast Cancer | Korea, Republic of | NCT05293470 | |
|
Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma |
Newly Diagnosed and Recurrent Glioblastoma | Phase1 |
France Germany Israel Italy Portugal Spain United States View All
|
NCT05739942 |
|
Study of Out of Specification for Tisagenlecleucel |
B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma | Phase3 | Japan | NCT04094311 |
|
Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer |
Prostatic Neoplasms, Castration-Resistant | Phase1 |
Australia South Africa |
NCT04597411 |
|
Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies |
Heterozygous or Homozygous Familial Hypercholesterolemia | Phase3 |
Brazil France Greece Israel Italy Lebanon Netherlands Norway Poland Slovenia South Africa Spain Switzerland Turkey United Kingdom United States View All
|
NCT05682378 |
|
A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma |
Follicular Lymphoma (FL) | Phase3 |
Australia Czechia Hungary Korea, Republic of Poland Romania Singapore Slovakia Spain Taiwan View All
|
NCT05888493 |
|
Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension. |
Chronic Spontaneous Urticaria | Phase3 |
Argentina Australia Brazil Bulgaria Canada Czechia France Germany Hungary India Italy Korea, Republic of Malaysia Mexico Netherlands Poland Slovakia Spain Switzerland Taiwan Thailand Turkey United Kingdom Vietnam View All
|
NCT06042478 |
|
Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function |
Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Phase2 |
France Germany Italy Spain View All
|
NCT06004661 |